Medical - Devices
Compare Stocks
2 / 10Stock Comparison
UFPT vs DOW
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
UFPT vs DOW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Chemicals |
| Market Cap | $1.68B | $27.71B |
| Revenue (TTM) | $603M | $39.33B |
| Net Income (TTM) | $68M | $-2.76B |
| Gross Margin | 28.3% | 6.2% |
| Operating Margin | 15.3% | -2.3% |
| Forward P/E | 23.0x | 13.0x |
| Total Debt | $154M | $19.60B |
| Cash & Equiv. | $20M | $3.82B |
UFPT vs DOW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| UFP Technologies, I… (UFPT) | 100 | 482.6 | +382.6% |
| Dow Inc. (DOW) | 100 | 99.7 | -0.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UFPT vs DOW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UFPT is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.01
- Rev growth 19.5%, EPS growth 15.7%, 3Y rev CAGR 19.4%
- 7.7% 10Y total return vs DOW's 14.6%
DOW carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 0.76, yield 5.4%, current ratio 1.97x
- Lower P/E (13.0x vs 23.0x)
- Beta 0.76 vs UFPT's 1.01
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.5% revenue growth vs DOW's -7.0% | |
| Value | Lower P/E (13.0x vs 23.0x) | |
| Quality / Margins | 11.3% margin vs DOW's -7.0% | |
| Stability / Safety | Beta 0.76 vs UFPT's 1.01 | |
| Dividends | 5.4% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +39.8% vs UFPT's -0.6% | |
| Efficiency (ROA) | 10.5% ROA vs DOW's -4.6%, ROIC 12.7% vs 0.6% |
UFPT vs DOW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
UFPT vs DOW — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
UFPT leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DOW is the larger business by revenue, generating $39.3B annually — 65.2x UFPT's $603M. UFPT is the more profitable business, keeping 11.3% of every revenue dollar as net income compared to DOW's -7.0%. On growth, UFPT holds the edge at +3.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $603M | $39.3B |
| EBITDAEarnings before interest/tax | $116M | $1.3B |
| Net IncomeAfter-tax profit | $68M | -$2.8B |
| Free Cash FlowCash after capex | $79M | -$2.0B |
| Gross MarginGross profit ÷ Revenue | +28.3% | +6.2% |
| Operating MarginEBIT ÷ Revenue | +15.3% | -2.3% |
| Net MarginNet income ÷ Revenue | +11.3% | -7.0% |
| FCF MarginFCF ÷ Revenue | +13.1% | -5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.4% | -6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.7% | -68.2% |
Valuation Metrics
DOW leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, DOW's 14.1x EV/EBITDA is more attractive than UFPT's 15.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.7B | $27.7B |
| Enterprise ValueMkt cap + debt − cash | $1.8B | $43.5B |
| Trailing P/EPrice ÷ TTM EPS | 24.88x | -10.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.97x | 13.02x |
| PEG RatioP/E ÷ EPS growth rate | 0.66x | — |
| EV / EBITDAEnterprise value multiple | 15.70x | 14.06x |
| Price / SalesMarket cap ÷ Revenue | 2.79x | 0.69x |
| Price / BookPrice ÷ Book value/share | 4.02x | 1.56x |
| Price / FCFMarket cap ÷ FCF | 21.31x | — |
Profitability & Efficiency
UFPT leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
UFPT delivers a 17.4% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-15 for DOW. UFPT carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOW's 1.12x. On the Piotroski fundamental quality scale (0–9), UFPT scores 6/9 vs DOW's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +17.4% | -15.4% |
| ROA (TTM)Return on assets | +10.5% | -4.6% |
| ROICReturn on invested capital | +12.7% | +0.6% |
| ROCEReturn on capital employed | +16.1% | +0.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 |
| Debt / EquityFinancial leverage | 0.36x | 1.12x |
| Net DebtTotal debt minus cash | $134M | $15.8B |
| Cash & Equiv.Liquid assets | $20M | $3.8B |
| Total DebtShort + long-term debt | $154M | $19.6B |
| Interest CoverageEBIT ÷ Interest expense | 9.42x | -1.51x |
Total Returns (Dividends Reinvested)
UFPT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UFPT five years ago would be worth $40,422 today (with dividends reinvested), compared to $7,452 for DOW. Over the past 12 months, DOW leads with a +39.8% total return vs UFPT's -0.6%. The 3-year compound annual growth rate (CAGR) favors UFPT at 15.3% vs DOW's -5.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -2.3% | +60.1% |
| 1-Year ReturnPast 12 months | -0.6% | +39.8% |
| 3-Year ReturnCumulative with dividends | +53.1% | -15.3% |
| 5-Year ReturnCumulative with dividends | +304.2% | -25.5% |
| 10-Year ReturnCumulative with dividends | +766.2% | +14.6% |
| CAGR (3Y)Annualised 3-year return | +15.3% | -5.4% |
Risk & Volatility
DOW leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DOW is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than UFPT's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOW currently trades 90.1% from its 52-week high vs UFPT's 79.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.01x | 0.76x |
| 52-Week HighHighest price in past year | $274.93 | $42.74 |
| 52-Week LowLowest price in past year | $173.88 | $20.40 |
| % of 52W HighCurrent price vs 52-week peak | +79.4% | +90.1% |
| RSI (14)Momentum oscillator 0–100 | 60.6 | 59.4 |
| Avg Volume (50D)Average daily shares traded | 214K | 14.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates UFPT as "Buy" and DOW as "Hold". Consensus price targets imply 36.6% upside for UFPT (target: $298) vs 2.7% for DOW (target: $40). DOW is the only dividend payer here at 5.44% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $298.00 | $39.55 |
| # AnalystsCovering analysts | 2 | 35 |
| Dividend YieldAnnual dividend ÷ price | — | +5.4% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $2.09 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
UFPT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DOW leads in 2 (Valuation Metrics, Risk & Volatility).
UFPT vs DOW: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is UFPT or DOW a better buy right now?
For growth investors, UFP Technologies, Inc.
(UFPT) is the stronger pick with 19. 5% revenue growth year-over-year, versus -7. 0% for Dow Inc. (DOW). UFP Technologies, Inc. (UFPT) offers the better valuation at 24. 9x trailing P/E (23. 0x forward), making it the more compelling value choice. Analysts rate UFP Technologies, Inc. (UFPT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UFPT or DOW?
On forward P/E, Dow Inc.
is actually cheaper at 13. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — UFPT or DOW?
Over the past 5 years, UFP Technologies, Inc.
(UFPT) delivered a total return of +304. 2%, compared to -25. 5% for Dow Inc. (DOW). Over 10 years, the gap is even starker: UFPT returned +766. 2% versus DOW's +14. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UFPT or DOW?
By beta (market sensitivity over 5 years), Dow Inc.
(DOW) is the lower-risk stock at 0. 76β versus UFP Technologies, Inc. 's 1. 01β — meaning UFPT is approximately 33% more volatile than DOW relative to the S&P 500. On balance sheet safety, UFP Technologies, Inc. (UFPT) carries a lower debt/equity ratio of 36% versus 112% for Dow Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UFPT or DOW?
By revenue growth (latest reported year), UFP Technologies, Inc.
(UFPT) is pulling ahead at 19. 5% versus -7. 0% for Dow Inc. (DOW). On earnings-per-share growth, the picture is similar: UFP Technologies, Inc. grew EPS 15. 7% year-over-year, compared to -335. 0% for Dow Inc.. Over a 3-year CAGR, UFPT leads at 19. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UFPT or DOW?
UFP Technologies, Inc.
(UFPT) is the more profitable company, earning 11. 3% net margin versus -6. 6% for Dow Inc. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UFPT leads at 15. 3% versus 0. 7% for DOW. At the gross margin level — before operating expenses — UFPT leads at 28. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UFPT or DOW more undervalued right now?
On forward earnings alone, Dow Inc.
(DOW) trades at 13. 0x forward P/E versus 23. 0x for UFP Technologies, Inc. — 10. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UFPT: 36. 6% to $298. 00.
08Which pays a better dividend — UFPT or DOW?
In this comparison, DOW (5.
4% yield) pays a dividend. UFPT does not pay a meaningful dividend and should not be held primarily for income.
09Is UFPT or DOW better for a retirement portfolio?
For long-horizon retirement investors, Dow Inc.
(DOW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), 5. 4% yield). Both have compounded well over 10 years (DOW: +14. 6%, UFPT: +766. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UFPT and DOW?
These companies operate in different sectors (UFPT (Healthcare) and DOW (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: UFPT is a small-cap high-growth stock; DOW is a mid-cap income-oriented stock. DOW pays a dividend while UFPT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.